| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/13/2001 | CA2401454A1 G-protein coupled receptors |
| 09/13/2001 | CA2401398A1 Dna encoding human acid-sensing ion channel bnac4 (asic4) |
| 09/13/2001 | CA2399943A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399913A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | CA2399202A1 Use of recombinant antigens to determine the immune status of an animal |
| 09/12/2001 | EP1132479A1 Protein expression vector and utilization thereof |
| 09/12/2001 | EP1132478A2 Helper virus for the preparation of recombinant viral recombinants |
| 09/12/2001 | EP1132476A1 Inorganic Pyrophosphatases from Lepidoptera |
| 09/12/2001 | EP1132475A1 Novel serine protease bssp2 |
| 09/12/2001 | EP1132473A1 Novel serine protease bssp6 |
| 09/12/2001 | EP1132471A2 TNF-binding proteins |
| 09/12/2001 | EP1132469A2 Methods for separating nucleic acids from Protein-nucleic acids complexes |
| 09/12/2001 | EP1132468A1 MAST CELL-SPECIFIC SIGNAL TRANSDUCING MOLECULES AND cDNAS THEREOF |
| 09/12/2001 | EP1132404A2 Acylated insulin |
| 09/12/2001 | EP1132401A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 09/12/2001 | EP1131636A1 Antibodies to peptides that target git receptors and related methods |
| 09/12/2001 | EP1131635A1 An immunoassay for the determination of transmissible spongiform encephalopathies in bovine |
| 09/12/2001 | EP1131448A2 Producing antimicrobial cationic peptides as fusion proteins |
| 09/12/2001 | EP1131433A1 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131358A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131355A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
| 09/12/2001 | EP1131350A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 09/12/2001 | EP1131349A2 Potassium channel interactors and uses therefor |
| 09/12/2001 | EP1131333A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 09/12/2001 | EP1131079A1 Small functional units of antibody heavy chain variable regions |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP1047445A4 Modified enzymes and their use for peptide synthesis |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0781348B1 Process for manufacturing cyclosporin a by highly productive fusant strain |
| 09/12/2001 | EP0766736B1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/12/2001 | EP0666751B1 Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312858A Bactericidal/permeability-increasing protein delation analogs |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1070867C Trefoil peptide dimer |
| 09/12/2001 | CN1070866C Superagonists and antagonists and superantagonists of H IL-6, and 3-D modelling method for their selection |
| 09/11/2001 | US6288215 Immunoglobulin for the detection of cooked and uncooked pork |
| 09/11/2001 | US6288214 Antibody which binds to preferential peptide and prevents bacterial infection |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6288032 Polypeptides for osteoporosis and other bone disorder treatment |
| 09/11/2001 | US6287866 β-casein expressing constructs |
| 09/11/2001 | US6287861 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 09/11/2001 | US6287836 Histidine kinase from Streptococcus pneumoniae and compositions therecontaining |
| 09/11/2001 | US6287833 Arabinitol oxidoreductase; for use in the diagnosis of microorganismal infection |
| 09/11/2001 | US6287827 Fermentation of nocardia; administered to treat drug or antibiotic resistant grampositive bacterial infections |
| 09/11/2001 | US6287817 Administering fusion protein of single chain fv molecule against transcytotic receptor linked to therapeutic protein; delivers protein to epithelial cell; treatment of cystic fibrosis |
| 09/11/2001 | US6287816 BMP-9 compositions |
| 09/11/2001 | US6287811 Biologically active bactericidal/permeability-increasing protein fragments |
| 09/11/2001 | US6287806 Method for producing a biologically active recombinant cysteine-free peptide |
| 09/11/2001 | US6287804 nrdG |
| 09/11/2001 | US6287803 Polynucleotides encoding a novel era polypeptide |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287793 Diagnostic methods for alzheimer's disease |
| 09/11/2001 | US6287788 The neuropeptide galanin and its receptors hold great promise as targets for the development of novel therapeutic agents. |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287785 Homogenous enzyme immunoassay process |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287756 Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/11/2001 | US6287559 Cloning and recombinant production of vespid venom hyaluronidases, and immunological therapies based thereon |
| 09/11/2001 | US6287554 Chicken interleukin-15 and uses thereof |
| 09/11/2001 | US6287537 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 09/11/2001 | CA2208960C Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 09/11/2001 | CA2021528C Muteins of human erythropoietin, the preparation thereof and the use thereof |
| 09/07/2001 | WO2001064942A1 Protein scaffolds for antibody mimics and other binding proteins |
| 09/07/2001 | WO2001064935A1 Manufacture and purification of cyclosporin a |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064929A1 Production of antibodies in transgenic plastids |
| 09/07/2001 | WO2001064922A2 Heterologous expression of neisserial proteins |
| 09/07/2001 | WO2001064920A2 Hybrid expression of neisserial proteins |
| 09/07/2001 | WO2001064901A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis |
| 09/07/2001 | WO2001064889A2 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064877A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064876A2 Human schizophrenia gene |
| 09/07/2001 | WO2001064874A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 09/07/2001 | WO2001064862A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 09/07/2001 | WO2001064843A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | WO2001064837A2 β NETRIN AND USES THEREOF |
| 09/07/2001 | WO2001064754A1 Gene recombinant antibody and its fragment |
| 09/07/2001 | WO2001064751A2 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | WO2001064750A2 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | WO2001064749A2 Method for preparing anti-mif antibodies |
| 09/07/2001 | WO2001064748A1 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 09/07/2001 | WO2001064737A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/07/2001 | WO2001064707A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | WO2001064703A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/07/2001 | WO2001064047A1 Process for producing soybean protein hydrolyzate |
| 09/07/2001 | WO2001055449A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055440A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055329A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055306A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001016289A3 Zymogen activation system |
| 09/07/2001 | WO2001005956A3 Sialyation of n-linked glycoproteins in the baculovirus expression vector system |